VIVS - VivoSim Labs, Inc.

https://vivosim.ai

Momentum: Bearish

Recent News

Bullish

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - VivoSim Labs ( NASDAQ:VIVS )

Benzinga • 1 month ago • score: 0.24

SAN DIEGO, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- VivoSim Labs, Inc.

Bullish

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

GlobeNewswire • 1 month ago • score: 0.24

Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in San Diego, California.

52W High

$21.96

52W Low

$1.41

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.04

Valuation

As of 2025-03-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.34

EV/Revenue (<3 favorable)

39.56

P/S (TTM) (<3 favorable)

35.75

P/B (<3 favorable)

0.47

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

1.00%

Institutions (25–75% balanced)

6.52%

Shares Outstanding

2,599,800

Float

2,573,800

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-03-31 (Overview)

Revenue (TTM)

144,000

Gross Profit (TTM)

-4,886,000

EPS (TTM)

-1.70

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-61.84%

ROE (TTM) (>15% strong)

-0.35%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.76

Momentum

Bearish momentum

Value

0.5454

0.4223

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025